This inventor holds 2 USPTO granted patents. Top assignee: Basf Aktiengesellschaft. Active years: 2000-2003.
Location History:
- Dossenheim, DE (2000)
- Eppelheim, DE (2003)
Company Filing History:
Years Active: 2000-2003
Title: Martin Raditsch: Innovator in Mucosal Permeability and Thrombin Inhibition
Introduction
Martin Raditsch is a notable inventor based in Eppelheim, Germany. He has made significant contributions to the field of polymer chemistry, particularly in the development of copolymers that enhance mucosal permeability. With a total of 2 patents, his work has implications in various medical applications.
Latest Patents
Raditsch's latest patents include innovative uses of (meth)acrylic acid copolymers to increase the permeability of mucous membranes. These copolymers utilize comonomers such as (meth)acrylic esters and other monomers capable of free-radical polymerization. The molar ratio of (meth)acrylic acid to comonomers can vary from 99:1 to 1:99, showcasing the versatility of his approach. Another significant patent involves thrombin muteins as antidotes for thrombin inhibitors, which could have important therapeutic applications.
Career Highlights
Martin Raditsch is currently employed at BASF Aktiengesellschaft, a leading chemical company known for its innovative solutions. His work at BASF has allowed him to explore and develop new materials that can have a profound impact on healthcare and pharmaceuticals.
Collaborations
Throughout his career, Raditsch has collaborated with esteemed colleagues such as Thomas Friedrich and Claus Bollschweiler. These partnerships have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Martin Raditsch's contributions to the field of polymer chemistry, particularly in mucosal permeability and thrombin inhibition, highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving therapeutic options and enhancing patient care.